News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
167 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19344)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Policy
Advaxis Submits Conditional MAA for Axalimogene Filolisbac for the Second-Line Treatment of Metastatic Cervical Cancer in EU
The MAA submission is centered around the encouraging results from the GOG-0265 study.
February 13, 2018
·
6 min read
Pharm Country
Medidata Introduces New Edge Family of Products for Clinical Operations at SCOPE 2018
Today at SCOPE, Medidata Solutions is introducing the Edge family of products, a holistic suite of intelligent trial planning and management solutions that seamlessly address today’s operational and regulatory requirements.
February 13, 2018
·
4 min read
BioMidwest
Colorado’s Viveve Closes $32.4M Offering
Viveve intends to use the cash for supporting the commercialization of its products, clinical research and development, working capital and general corporate purposes.
February 13, 2018
·
4 min read
Deals
Mallinckrodt Completes Acquisition of Sucampo
The tender offer by a subsidiary of Mallinckrodt for all of the outstanding shares of Sucampo Class A common stock expired as scheduled at 8:00 a.m. on February 13, 2018.
February 13, 2018
·
8 min read
Business
Accelerated Cure Project Launches Collaborative Research Program With Regeneron Genetics Center to Sequence DNA of Multiple Sclerosis Patients
The RGC will use its fully-automated sample preparation and data processing, and cutting-edge cloud-based informatics to sequence the exomes in DNA samples from the ACP Repository.
February 13, 2018
·
3 min read
Business
TetraGenetics Expands Collaboration With Top Tier Biotech Partner
Tetragenetics, Inc. announced today a significant expansion of an existing strategic R&D collaboration with an industry leading biotech partner.
February 13, 2018
·
1 min read
Pharm Country
ABEC Expands Manufacturing Capability of Single-Use Disposable Containers for Biopharmaceutical Manufacturing
ABEC announced the completion of its second ISO-7 cleanroom for single-use disposable container (DC) manufacturing.
February 13, 2018
·
2 min read
Business
Cytobank and the FDA Collaborate to Improve Immunotherapy Development
Cytobank and the FDA are collaborating to develop machine learning-based methods for characterizing the morphology of multipotent mesenchymal stromal cells (MSCs).
February 13, 2018
·
2 min read
Drug Development
Imara Doses First Patient in Phase IIa Clinical Trial of IMR-687 for Sickle Cell Disease
IMR-687 is designed as an oral therapy for once-daily dosing to address both the underlying red and white blood cell pathologies associated with SCD.
February 13, 2018
·
4 min read
Business
Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2017 Financial Results on February 27, 2018
Management will host a conference call and webcast discussion of the results and provide a general corporate update.
February 13, 2018
·
2 min read
Previous
6 of 17
Next